Carole Ho, Chief Medical Officer: Denali Therapeutics DNLI Sell · Filed 24/08/22

Trade details

Type: Insider sale
Amount: $344,132.18
Shares · price: 14,098 sh · $24.41 a share
Held after: 124,717 sh
Stock: Denali Therapeutics DNLI
Person: Carole HoChief Medical Officer
Trade date: 24/08/21
Filed: 24/08/22
Days to filing: 1 days

Sold 10.2% of holdings

Share of holding sold: 10.2%

Denali Therapeutics trades, last 26 weeks

What else happened in Denali Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

Carole Ho's recent trades

Carole HoDirector
Planned saleBeam Therapeutics
Planned sale
Beam Therapeutics
BEAM
$2.7M
87,784 sh
$2.7M
Filed 04/14
Traded 04/14
Carole HoFormer Affiliate
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$801.4K
39,490 sh
$801.4K
Filed 02/05
Traded 02/05
Carole HoFormer Affiliate
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$3.2M
150,000 sh
$3.2M
Filed 02/04
Traded 02/04
Carole HoFormer Affiliate
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$3.3M
150,000 sh
$3.3M
Filed 02/03
Traded 02/03
Carole HoConsultant
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$284.1K
17,218 sh
$284.1K
Filed 01/06
Traded 01/06

Carole Ho, Chief Officer — sold $344.1K of Denali Therapeutics DNLI · 10.2% of holdings · 10b5-1 plan | Whalegun